πŸ‡ΊπŸ‡Έ FDA
Patent

US 7101909

Calcium channel drugs and uses

granted A61KA61K47/545A61K47/55

Quick answer

US patent 7101909 (Calcium channel drugs and uses) held by Theravance, Inc. expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K47/545, A61K47/55